| Group I | Group II | P-value |
---|---|---|---|
 | n = 55 | n = 104 |  |
Age (years) | 42.02 ± 10.57 | 40.26 ± 12.97 | 0.389 |
Gender | 7 male | 19 male | 0.37 |
48 female | 85 female | ||
Duration of symptoms (months) | 57.56 ± 9.71 | 56.27 ± 9.20 | 0.4 |
AF 1 | 33 (60%) | 33 (31.7%) | 0.001 |
MVA 2 (cm 2 ) | 0.91 ± 0.23 | 1 ± 0.22 cm2 | 0.025 |
MDG 3 (mmHg) | 13.91 ± 5.43 | 11.77 ± 3.61 | 0.003 |
LVEF 4 (%) | 65.22 ± 5.63 | 64.88 ± 5.49 | 0.7 |
LAD 5 (mm) | 51.40 ± 7.74 | 48.39 ± 7.9 | 0.023 |
LA 6 (cm 2 ) | 33.09 ± 6.39 | 30.83 ± 7.08 | 0.027 |